11 Results

People

  1. Autio
    Autio
  2. Abida
    Abida
  3. Danila
    Danila
  4. Morris
    Morris
  5. Scher
    Scher
  6. Slovin
    Slovin
  7. Breen
    Breen
  8. Carlo
    Carlo
  9. Rathkopf
    Rathkopf
  10. Robson
    Robson

Groups

  1. Department of Medicine (11)
  2. Genitourinary Oncology Service (11)
  3. Solid Tumor Oncology Division (11)
  4. Hematologic Malignancies, Division of (3)
  5. Breast Medicine Service (2)
  6. Center for Pancreatic Cancer Research (2)
  7. Clinical Genetics Service (2)
  8. Graduate Medical Education (2)
  9. Population Sciences Research Program (2)
  10. Sloan Kettering Institute Postdocs (2)
  1. "article"
  2. "Karen Autio"
Formats
  1. Journal Article (11)
Groups
  1. Department of Medicine (11)
  2. Genitourinary Oncology Service (11)
  3. Solid Tumor Oncology Division (11)
  4. Hematologic Malignancies, Division of (3)
  5. Breast Medicine Service (2)
  6. Center for Pancreatic Cancer Research (2)

More Groups

People
  1. Karen Autio (11)
  2. Daniel Danila (4)
  3. Howard Scher (4)
  4. Michael Morris (4)
  5. Wassim Abida (4)
  6. Dana Rathkopf (3)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (1)
  4. 2021 (2)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (3)
  2. Cancer (1)
  3. Cancer Cell (1)
  4. Cancer Epidemiology Biomarkers and Prevention (1)
  5. European Urology (1)
  6. Journal of Immunotherapy and Precision Oncology (1)

More Publications

Publishers
  1. Biomed Central Ltd (3)
  2. Elsevier Science, Inc. (3)
  3. American Association for Cancer Research (1)
  4. Cell Press (1)
  5. Innovative Healthcare Institute (1)
  6. John Wiley & Sons (1)

More Publishers

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer
    Journal Article

    Chen, N.; McGrath, C. B.; Ericsson, C. I.; Vaselkiv, J. B.; Rencsok, E. M.; Stopsack, K. H.; Guard, H. E.; Autio, K. A.; Rathkopf, D. E.; Enting, D.; more...
    Cancer Epidemiology Biomarkers and Prevention (2024)

    Fulltext@MSK | Save
  • Evaluating immune-related adverse events using PRO-CTCAE in a phase II study of ipilimumab for hormone-sensitive prostate cancer
    Journal Article

    Vargas P. de Almeida, D.; Anderson, J. M.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Cohn, E. D.; Baser, R. E.; Scher, H. I.; Autio, K. A.
    Journal of Immunotherapy and Precision Oncology (2023)

    Fulltext@MSK | Save
  • Clinical impact of a rapid genetic testing model for advanced prostate cancer patients
    Journal Article

    Breen, K. E.; Symecko, H.; Spielman, K.; Gebert, R.; Shah, I. H.; Pundock, S.; Batson, M.; Narayan, V. K.; Stadler, Z. K.; Autio, K. A.; more...
    Journal of Urology (2023)

    Fulltext@MSK | Save
  • First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)
    Journal Article

    Autio, K. A.; Higano, C. S.; Nordquist, L.; Appleman, L. J.; Zhang, T.; Zhu, X. H.; Babiker, H.; Vogelzang, N. J.; Prasad, S. M.; Schweizer, M. T.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality
    Journal Article

    Keegan, N. M.; Vasselman, S. E.; Barnett, E. S.; Nweji, B.; Carbone, E. A.; Blum, A.; Morris, M. J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; more...
    Prostate (2022)

    Fulltext@MSK | Save
  • CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072): An open-label dose-finding and first-in-human study
    Journal Article

    Naing, A.; Thistlethwaite, F.; de Vries, E. G. E.; Eskens, F. A. L. M.; Uboha, N.; Ott, P. A.; LoRusso, P.; Garcia-Corbacho, J.; Boni, V.; Bendell, J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): A first-in-human, dose-finding study
    Journal Article

    Sanborn, R. E.; Hamid, O.; de Vries, E. G. E.; Ott, P. A.; Garcia-Corbacho, J.; Boni, V.; Bendell, J.; Autio, K. A.; Cho, D. C.; Plummer, R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): A multicentre, multicohort, open-label, phase 1b trial
    Journal Article

    Naing, A.; Wong, D. J.; Infante, J. R.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K. P.; Autio, K. A.; Pant, S.; Bauer, T. M.; Drakaki, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • PEGylated IL-10 (pegilodecakin) induces systemic immune activation, CD8(+) T cell invigoration and polyclonal T cell expansion in cancer patients
    Journal Article

    Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Chan, I. H.; Shen, C.; Ratti, N. P.; Rojo, B.; Autio, K. A.; Wong, D. J.; Patel, M. R.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save